Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Castration-resistant prostate cancer registry: An observational study in the Netherlands.

Trial Profile

Castration-resistant prostate cancer registry: An observational study in the Netherlands.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Oct 2018

At a glance

  • Drugs Abiraterone (Primary) ; Antineoplastics (Primary) ; Cabazitaxel (Primary) ; Enzalutamide (Primary) ; Radium 223 chloride (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms CAPRI
  • Most Recent Events

    • 01 Aug 2013 Additional lead trial centres identified as reported by Netherlands Trial Register.
    • 01 Aug 2013 Status changed from planning to recruiting as reported by Netherlands Trial Register.
    • 22 Sep 2012 Status changed from not yet recruiting to planning as reported by Netherlands Trial Register record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top